Today: 20 June 2026

Cyclerion Therapeutics stock jumps in premarket after Medsteer deal — what CYCN investors watch next

Cyclerion Therapeutics stock jumps in premarket after Medsteer deal — what CYCN investors watch next

Cyclerion Therapeutics shares surged 46% to $2.01 premarket Tuesday after announcing an expanded exclusive collaboration with Medsteer for its CYC-126 depression program. The company aims to start a Phase 2 proof-of-concept study in late 2026, with initial data expected in 2027. Cyclerion flagged “substantial doubt” about its ability to continue as a going concern and said it needs more funding.
6 January 2026
··
Microchip Technology stock jumps about 4% premarket after sales forecast boost

Microchip Technology stock jumps about 4% premarket after sales forecast boost

Microchip Technology shares rose 4.1% to $69.82 in premarket trading after the company raised its fiscal Q3 net sales outlook to about $1.19 billion, above its previous range. The stock closed Monday at $67.06, up 3.12%. CEO Steve Sanghi cited strong bookings and a higher starting backlog for the March quarter. JPMorgan raised its price target to $85 following the update.
6 January 2026
···
AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

Health Canada approved AbbVie’s Maviret for acute and chronic hepatitis C in adults and children aged 3 and older. AbbVie shares were flat premarket at $220.18 after falling nearly 4% Monday. The approval followed a Priority Review based on Phase 3 data. Investors await AbbVie’s Jan. 14 appearance at the J.P. Morgan Healthcare Conference.
6 January 2026
··
Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer

Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer

Sabra Health Care REIT shares fell 0.4% to $19.08 premarket after naming Darrin Smith chief investment officer, effective Jan. 1. Smith’s base salary is set at $470,000, and CFO Michael Costa will add the treasurer role. Smith replaces Talya Nevo-Hacohen, who is retiring. Investors await the next quarterly results for updates on deal activity and funding costs.
6 January 2026
·
AEVA stock jumps 25% premarket after Nvidia DRIVE Hyperion win, Omni LiDAR launch at CES 2026

AEVA stock jumps 25% premarket after Nvidia DRIVE Hyperion win, Omni LiDAR launch at CES 2026

Aeva shares surged 24.6% to $16.31 in premarket trading after announcing its 4D lidar was selected for Nvidia’s DRIVE Hyperion platform at CES. The company also introduced its Omni short-range lidar sensor, developed with LG Innotek, with customer pilots set for late 2026. Investors await further details on customers and production timelines during CES.
6 January 2026
··
2026 IRS tax brackets hit paychecks now — what the new standard deduction and deductions mean for refunds

2026 IRS tax brackets hit paychecks now — what the new standard deduction and deductions mean for refunds

The IRS raised 2026 federal income-tax bracket thresholds and increased the standard deduction to $16,100 for singles and $32,200 for joint filers. New deductions for tips, overtime, and seniors take effect, while the top marginal rate remains 37% above $640,600 for singles. Employers are updating payroll withholding tables. Taxpayers filing 2025 returns will see these changes reflected in new forms.
6 January 2026
Delta Air Lines stock nudges higher in premarket after Goldman lifts target ahead of earnings

Delta Air Lines stock nudges higher in premarket after Goldman lifts target ahead of earnings

Delta Air Lines shares rose 0.3% to $72.03 in premarket trading Tuesday after Goldman Sachs raised its price target to $77 ahead of Delta’s January 13 earnings webcast. The stock closed up 4% Monday, outpacing airline peers. Delta added flights in the Caribbean after FAA airspace closures disrupted weekend travel. Oil prices fell Tuesday, easing jet fuel cost concerns.
6 January 2026
···
Novo Nordisk stock jumps premarket as $149 Wegovy pill hits U.S. market

Novo Nordisk stock jumps premarket as $149 Wegovy pill hits U.S. market

Novo Nordisk’s U.S.-listed shares rose about 4% in premarket trading after the company launched an oral version of its Wegovy weight-loss drug, priced from $149 a month for some cash-paying patients. The stock traded at $57.29, up from $55.11. Investors are watching early demand and await the company’s February 4 results for margin outlook. The launch comes amid restructuring and job cuts at Novo’s U.S. operations.
6 January 2026
···
UK Self Assessment deadline: 5.65 million still haven’t filed, HMRC warns

UK Self Assessment deadline: 5.65 million still haven’t filed, HMRC warns

HMRC said 5.65 million people still need to file 2024/25 Self Assessment tax returns before the Jan. 31 deadline. Missing the deadline triggers an automatic £100 fine, with further penalties and interest for late filing or payment. More than 6.36 million have already filed. Some self-employed people must also make advance “payments on account” toward next year’s tax bill.
6 January 2026
Zeta Global stock jumps in premarket after OpenAI deal for Athena AI marketing agent

Zeta Global stock jumps in premarket after OpenAI deal for Athena AI marketing agent

Zeta Global shares rose 10.8% to $24.00 in premarket trading Tuesday after announcing a collaboration with OpenAI for its Athena product. The company expanded beta access to two AI-powered apps and said TKO Group Holdings participated in early testing. The stock closed Monday at $21.67, up 8.8%, with 13.6 million shares traded. Athena’s full launch is planned by the end of Q1 2026.
6 January 2026
··
Natural gas price stock UNG drops again in premarket as warm-weather forecast weighs on futures

Natural gas price stock UNG drops again in premarket as warm-weather forecast weighs on futures

United States Natural Gas Fund dropped 2.2% to $11.37 in premarket trading Tuesday as U.S. natural gas futures fell 2.7% to $3.427 per mmBtu. The decline follows warmer-than-normal weather forecasts and a 3.6% loss for UNG on Monday. Traders await the U.S. storage report due Jan. 8. Supply remains high, with output averaging 109.2 bcfd so far in January.
6 January 2026
···
Natural gas ETFs get hit as warm-weather outlook drags futures; UNG, BOIL, KOLD in focus

Natural gas ETFs get hit as warm-weather outlook drags futures; UNG, BOIL, KOLD in focus

U.S. natural gas futures fell 2.7% early Tuesday to $3.43/mmBtu, extending Monday’s 5% drop on warmer forecasts. UNG closed down 3.6%, BOIL lost 10.9%, and KOLD rose 11.2% Monday. Traders await Thursday’s storage data and mid-January weather updates. Lower 48 gas output held near 109–111 bcf/day, with LNG export flows near 19–20 bcf/day.
6 January 2026
·····
AI ETFs before the bell: Nvidia CES chip push lifts funds as bubble warnings linger

AI ETFs before the bell: Nvidia CES chip push lifts funds as bubble warnings linger

Nvidia detailed its Vera Rubin AI platform at CES, while Intel launched its Panther Lake laptop chip tied to its 18A process. AI-focused ETFs traded mostly higher in premarket U.S. action; BOTZ rose 2.4%, AIQ gained 1.1%. Nvidia shares slipped 0.4%, AMD fell 1.1%. Traders are watching rate expectations ahead of Friday’s U.S. jobs report.
6 January 2026
·······
1 … 996 997 998 999 1,000 … 2,087

Stock Market Today

  • Parabilis Medicines Director Buys $474,000 Shares Post-IPO, Signaling Confidence in PBLS Stock
    June 20, 2026, 1:37 PM EDT. Parabilis Medicines (NASDAQ:PBLS) director Alan Sebulsky purchased 17,500 shares for approximately $474,000 shortly after the company's IPO. The purchase, made through his investment vehicle Apothecary Capital LLC, raised his indirect holdings to 30,000 shares. The transaction price of $27.06 per share exceeded the June 15 closing price by about 8.2%, indicating strong confidence. Parabilis focuses on developing cell-penetrating miniproteins targeting cancer cells and has a $3.29 billion market cap. Sebulsky, noted for board roles at Jazz Pharmaceuticals and Arrow International, increasing his stake could be seen as a bullish indicator for investors assessing PBLS.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq gets boost from AI chip stocks; Fed rate question stays in focus

20 June 2026
Intel soared 10.6% after President Trump announced Apple will partner with the company on U.S. chip design and manufacturing, fueling a semiconductor-led rally that lifted the S&P 500 by 0.93% and the Nasdaq by 2.43% in a holiday-shortened week, even as investors remain wary of persistent inflation and potential Fed rate hikes.
Go toTop